Telcon RF Pharmaceutical Overview

  • Founded
  • 1999
Founded
  • Status
  • Public
  • Employees
  • 157
Employees
  • Stock Symbol
  • 200230
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $4.41
  • (As of Friday Closing)

Telcon RF Pharmaceutical General Information

Description

Telcon RF Pharmaceutical Inc manufactures wireless communication equipment. It is engaged in developing connectors for input and output port, board to board, cable assembly, and board to mount used in wireless communication equipment. The company also supply's RF coaxial connectors.

Contact Information

Ownership Status
Publicly Held
Financing Status
Private Equity-Backed
Primary Industry
Electrical Equipment
Other Industries
Connectivity Products
Fiberoptic Equipment
Stock Exchange
KRX
Primary Office
  • 54, Gongse-ro
  • Giheung-gu
  • Yongin-si, Gyeonggi-do
  • South Korea
+82 000-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Telcon RF Pharmaceutical Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.41 $4.52 $2.51 - $10.45 $377M 85.4M 1.54M -$0.49

Telcon RF Pharmaceutical Financials Summary

In Thousands,
USD
TTM 30-Sep-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 577,770 355,657 621,325 1,042,891
Revenue 28,977 48,531 52,505 36,288
EBITDA (35,519) (39,954) (5,749) (13,800)
Net Income (40,395) (45,151) (12,514) (14,498)
Total Assets 125,287 113,651 162,563 196,183
Total Debt 17,839 10,508 17,132 61,913
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Telcon RF Pharmaceutical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Telcon RF Pharmaceutical‘s full profile, request access.

Request a free trial

Telcon RF Pharmaceutical Executive Team (1)

Name Title Board Seat Contact Info
Jin-hun Lim Chief Executive Officer and President
To view Telcon RF Pharmaceutical’s complete executive team members history, request access »

Telcon RF Pharmaceutical Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Telcon RF Pharmaceutical Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Telcon RF Pharmaceutical‘s full profile, request access.

Request a free trial

Telcon RF Pharmaceutical Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 10-Aug-2016 000000000 000.00 Drug Discovery
To view Telcon RF Pharmaceutical’s complete investments history, request access »